Becoming an allergy and immunology nurse practitioner requires a graduate NP degree (MSN or DNP), an active NP national board certification – most commonly the NPCB Family Nurse Practitioner (FNP-C) or the ANCC Adult-Gerontology Primary Care NP (AGPCNP-BC) – and clinical experience in allergy, asthma, and immunologic disease management. There is no allergy/immunology-specific NP board exam. Most career guides are vague on this point or imply a specialty certification exists – it does not at the NP level. Allergy/immunology NPs practice under a general NP credential and build specialty expertise through postgraduate training, mentorship, and procedural experience. Total timeline from BSN entry runs roughly 6–10 years depending on educational path and how quickly you move into the specialty.
The field is expanding rapidly. The scale of food allergy (more than 33 million Americans, per FARE), the steady expansion of biologic indications in asthma, atopic dermatitis, urticaria, and nasal polyps, and a limited supply of allergist-immunologists in many regions have all created demand for trained allergy APPs. For salary and compensation detail, see the companion allergy immunology NP salary guide.
Quick-scan summary
| Step | What’s required | Approximate timeline |
|---|---|---|
| BSN | Accredited pre-licensure nursing program | 4 years (ABSN: 12–18 months) |
| RN licensure + experience | NCLEX-RN + bedside clinical experience | 1–3 years post-BSN |
| NP graduate program | MSN or DNP (FNP or AGPCNP most common) | 2–3 years |
| Board certification | NPCB or ANCC national cert exam | Typically within a few months of graduation |
| Allergy/immunology experience | Practice in allergy or immunology setting | Ongoing from first NP position |
| Total | 6–10 years from BSN entry |
What does an allergy and immunology NP do?
Allergy and immunology is a dual-focus specialty: it covers hypersensitivity disorders (allergic rhinitis, asthma, food allergy, drug allergy, urticaria, anaphylaxis, atopic dermatitis, contact dermatitis) and primary immunodeficiency diseases (common variable immunodeficiency [CVID], selective IgA deficiency, specific antibody deficiency, combined immunodeficiencies). In practice, most allergy NPs spend the large majority of their time on the allergy and asthma side; immunodeficiency management is a smaller but clinically demanding component.
Core procedures and responsibilities:
- Allergy skin testing – Prick testing (SPT) and intradermal testing (IDT) for aeroallergens, food allergens, venoms, and drugs. NPs perform and interpret results independently in most allergy practices.
- Allergen immunotherapy (SCIT) – Subcutaneous immunotherapy involves building and maintaining allergen extract mixes, supervising injections, managing post-injection reactions, and adjusting dosing protocols. NPs can initiate and supervise SCIT programs in most states.
- Sublingual immunotherapy (SLIT) – FDA-approved sublingual allergen tablets (Odactra for house dust mite, Grastek for Timothy grass pollen, Ragwitek for short ragweed) involve prescription initiation, in-office first-dose observation, epinephrine auto-injector prescribing, and maintenance monitoring. (Palforzia, sometimes grouped with these, is an oral immunotherapy powder, covered below.)
- Biologic prescribing – Severe asthma and atopic dermatitis biologics now represent a major share of allergy NP prescribing volume:
- Dupilumab (Dupixent) – atopic dermatitis, moderate-to-severe asthma (eosinophilic phenotype or oral-steroid-dependent), CRSwNP, EoE, prurigo nodularis, eosinophilic-phenotype COPD (2024), chronic spontaneous urticaria (2025), bullous pemphigoid (2025)
- Omalizumab (Xolair) – allergic asthma, CRSwNP, chronic spontaneous urticaria, IgE-mediated food allergy (FDA-approved February 2024)
- Mepolizumab (Nucala) – eosinophilic asthma, CRSwNP, EGPA, HES, eosinophilic-phenotype COPD (May 2025)
- Benralizumab (Fasenra) – eosinophilic asthma, EGPA (September 2024)
- Tezepelumab (Tezspire) – severe asthma with no phenotype or biomarker restriction (TSLP inhibitor), CRSwNP (October 2025)
- Oral food challenges (OFC) – Supervised graded food challenges to diagnose or rule out food allergy. This is a key procedural skill, especially in pediatric allergy.
- Oral immunotherapy (OIT) – Peanut OIT gained an FDA-approved product with Palforzia in 2020, and many practices also run off-label OIT protocols. NPs run build-up and maintenance phases, manage reactions, and coordinate with families.
- Anaphylaxis management – Epinephrine auto-injector prescription, anaphylaxis action plan development, patient and family education, systemic reactions during immunotherapy procedures.
- Primary immunodeficiency management – For the immunology side: evaluating patients with recurrent infections, ordering and interpreting immunoglobulin panels, T/B/NK cell panels, complement levels. CVID patients often receive immunoglobulin replacement therapy (IVIG or SCIG) coordinated by their allergy/immunology team.
- Asthma management – Spirometry interpretation, asthma action plans, inhaler technique teaching, step therapy per GINA guidelines, trigger avoidance counseling.
NP track selection
Choosing the right NP program is the most consequential educational decision for aspiring allergy NPs. The choice depends primarily on what patient population you want to serve.
| NP track | Best fit for allergy/immunology | Reasoning |
|---|---|---|
| FNP (Family NP) | Most allergy practices | Allergy patients span all ages – pediatric food allergy, adolescent asthma, adult rhinitis and eosinophilic disease, elderly urticaria. FNP certification allows you to see every age group, which is the default expectation in most general allergy practices. |
| AGPCNP (Adult-Gerontology Primary Care NP) | Adult-only or academic allergy | Appropriate for adult allergy practices, academic AMC divisions focused on adult eosinophilic disease or severe asthma, and programs with a strong immunodeficiency component where the patient mix is predominantly adult. |
| PNP-PC (Pediatric Primary Care NP) | Pediatric allergy / food allergy programs | Pediatric allergy is a distinct practice setting – food allergy, allergic eosinophilic disorders, pediatric asthma, and OIT programs skew heavily toward children. PNP-PC is the right credential if your target is children’s hospital allergy divisions or pediatric private practice. |
| AGACNP (Adult-Gerontology Acute Care NP) | Not recommended for most allergy careers | Allergy/immunology is overwhelmingly outpatient. AGACNP scope covers acutely ill adult inpatients. The rare exception is hospital-based immunology consult services for critically ill immunodeficient patients. |
Bottom line: If you are uncertain, FNP is the most flexible credential for an allergy/immunology career. It is the most common NP certification held by practicing allergy APPs.
The certification landscape: what you need to know
Most online guides are vague or inaccurate on this point. Here is what exists in reality and what does not:
What exists outside NP certification (and what doesn’t):
- No national allergy/immunology board certification for RNs either: ANCC’s current credential list includes no allergy or immunology credential at any level. (Some online sources describe an ANCC “RNAAS” allergy credential; it does not appear on ANCC’s credentials chart.)
- AAAAI and ACAAI do not offer NP-specific credentialing exams.
- The American Board of Allergy and Immunology (ABAI) certifies physicians (MDs and DOs) only. NPs and PAs are not eligible for ABAI board certification.
What does not exist:
- There is no ANCC allergy/immunology NP board certification.
- There is no NPCB allergy/immunology specialty exam for NPs.
- There is no NP-level allergy certification that functions as a credential for state licensure or practice privileges.
What allergy/immunology NPs hold in practice: Most practicing allergy/immunology NPs carry one of these national certifications as their primary credential:
- FNP-C (Nurse Practitioner Certification Board [NPCB], formerly AANPCB, Family NP Certification)
- FNP-BC (ANCC Family NP Board Certification)
- AGPCNP-BC (ANCC Adult-Gerontology Primary Care NP Board Certification)
- CPNP-PC (PNCB Certified Pediatric Nurse Practitioner – Primary Care)
Specialty expertise is demonstrated through clinical experience, continuing education (AAAAI and ACAAI both offer allergy-specific CME), and in some cases postgraduate fellowship training.
Professional organizations: AAAAI and ACAAI
Two major professional societies anchor the allergy and immunology field. Both have allied health membership open to NPs and PAs.
AAAAI – American Academy of Allergy, Asthma & Immunology AAAAI runs one of the specialty’s two major annual CME conferences (the AAAAI Annual Meeting) and, jointly with ACAAI, sponsors the Joint Task Force on Practice Parameters, which produces the practice parameters that guide clinical care in the specialty. AAAAI offers allied health membership for NPs. Access to educational resources, job boards, and the Journal of Allergy and Clinical Immunology comes with membership.
ACAAI – American College of Allergy, Asthma and Immunology ACAAI also offers allied health membership and runs a separate annual meeting (ACAAI Annual Scientific Meeting), with a strong emphasis on practical clinical education for practicing allergists. Both organizations welcome NP members and provide legitimate CME credit.
Joining at least one of these organizations is standard practice for allergy NPs. The CME content, practice guideline access, and professional networking are all relevant to clinical practice and continuing competency.
Fellowship training: what’s available
This is an area where allergy/immunology differs materially from oncology, cardiology, or critical care: there are very few NP-specific allergy/immunology fellowship programs.
Most allergist training happens within physician (MD/DO) fellowship programs, which are 2-year ACGME-accredited programs. Some of these programs – particularly at large academic medical centers – have expanded to accept APPs (NPs and PAs) in an informal or non-ACGME capacity.
Formal, advertised APP fellowships in allergy/immunology are rare and change year to year, so verify any program directly with the division before applying. Where APP training exists, it is usually an informal or institution-specific arrangement, and entry usually requires direct outreach, a strong RN or NP clinical background in allergy-adjacent specialties (pulmonary, pediatrics, internal medicine), and willingness to work in a training role. Compensation and formal curriculum vary.
The realistic path for most allergy NPs is not fellowship but rather:
- An NP position in an allergy practice under supervision of an experienced allergist
- Deliberate skill-building in skin testing, immunotherapy administration, and biologic prescribing
- AAAAI or ACAAI CME to build clinical knowledge
- Accumulated experience over 2–4 years that becomes the demonstrable specialty expertise
The food allergy boom as a growth driver
The scale of food allergy in the US has materially changed the allergy NP job market. FARE (Food Allergy Research & Education) data places US food allergy prevalence at approximately 33 million people, with food allergy affecting nearly 8% of children (about 1 in 13) and roughly 1 in 10 adults. The most clinically significant driver for NP careers is the growth of oral immunotherapy programs.
FDA-approved OIT:
- Palforzia (peanut allergen powder) – FDA approved in January 2020 for ages 4–17, with initiation extended to ages 1–3 in July 2024. OIT programs require structured build-up phases with supervised dose escalations, maintenance dosing, and reaction management. This is NP-compatible procedural work.
Off-label OIT: Many major allergy centers run off-label OIT programs for milk and egg allergy using food products. NPs can participate in protocol design, patient selection, dose escalations, and follow-up – especially in academic pediatric settings.
The combination of Palforzia commercialization and expanding off-label OIT means allergy practices are actively hiring NPs who can run OIT programs. This is one of the most procedure-rich, patient-education-heavy roles in the specialty.
Education pathway
BSN to NP (traditional path)
Most allergy/immunology NPs follow this route:
- BSN program (4 years) at an ACEN- or CCNE-accredited school
- NCLEX-RN – Passing score required for RN licensure
- RN clinical experience – 1–3 years in a setting that builds relevant skills. Relevant backgrounds include medical-surgical, pediatrics, pulmonary/respiratory care, or primary care. There is no single prerequisite specialty.
- NP graduate program – MSN (2–3 years) or BSN-to-DNP (3–4 years). FNP or AGPCNP track depending on target patient population.
- NP board certification – FNP-C, FNP-BC, AGPCNP-BC, or CPNP-PC, typically taken soon after graduation.
- First allergy NP position – Entry into the specialty. Some candidates take an NP position in pulmonary or primary care first and later transition to allergy.
Post-graduate certificate (MSN to allergy-adjacent NP focus)
Nurses who hold an MSN with a clinical nurse specialist or a different NP population focus (e.g., women’s health) can pursue a post-master’s certificate in an NP population focus – typically FNP – without repeating the full MSN. This can reduce the additional training to 12–18 months of additional coursework and clinical hours, followed by the relevant board exam.
DNP (Doctor of Nursing Practice)
The DNP is a terminal practice degree. It does not change state licensure requirements or practice authority beyond what the MSN provides in most states. Some academic medical centers prefer a DNP for senior NP positions, particularly in research-adjacent or administrative roles; most clinical allergy NP positions do not require it.
Work settings
Allergy/immunology NPs work in a range of settings with meaningfully different day-to-day experiences:
| Setting | Description | NP role |
|---|---|---|
| Private allergy practice | Most common setting – single or multi-physician practice, outpatient only | High procedural volume (skin testing, SCIT), broad patient mix, often productivity-based compensation |
| Academic medical center | Large allergy/immunology division, complex referral cases, rare immunodeficiencies | Complex diagnostic work, research participation possible, collaborative atmosphere |
| Pediatric hospital (allergy dept) | Pediatric allergy focus – food allergy, asthma, atopic dermatitis, OIT programs | OFC and OIT program work, subspecialty PNP focus |
| Integrated health system | Primary care–aligned allergy services within large health system | Patient access focus, referral coordination, asthma management |
| Community health center / FQHC | Underserved populations, lower ceiling | NHSC loan repayment requires primary care practice at an approved site, so a specialty-only allergy role may not qualify; confirm eligibility before relying on it |
| Telehealth allergy | Emerging model – follow-up visits, SLIT monitoring, asthma management | Geographic flexibility, no procedural work (skin testing, SCIT not telehealth-compatible) |
Is allergy/immunology NP practice right for you?
Allergy and immunology is an outpatient specialty. If you value procedure-based work, long-term patient relationships, and the satisfaction of managing complex immune-mediated disease – it is a strong fit. If you want inpatient acute care, rapid patient turnover, or the variety of a primary care panel, this specialty will feel narrow.
Consider allergy/immunology if:
- You enjoy procedural work with immediate feedback (skin testing results, post-OFC outcomes)
- You find immunology intellectually engaging – the underlying mechanisms of IgE-mediated disease, complement, and primary immunodeficiency are conceptually interesting
- You want a predominantly Monday–Friday outpatient schedule
- You have a background in pediatrics and want to specialize in food allergy or pediatric asthma
- You want to be involved in biologic prescribing and OIT, which are high-growth areas
Look elsewhere if:
- You want inpatient work or hospital-based acute care
- You want a very broad primary care panel with wide variety
- You are uncomfortable with anaphylaxis risk (SCIT and OFC carry anaphylaxis risk that must be managed calmly and competently)
Related specialties to compare
Allergy/immunology has significant overlap with several other NP specialties:
- Pulmonology NP – Asthma is the primary overlap. Pulmonary NPs manage severe asthma from the airways side; allergy NPs manage it from the immune/inflammatory side. The patient populations partially overlap. See how to become a pulmonology NP.
- Rheumatology NP – Autoimmune disease is the shared territory. Some patients with CVID develop autoimmune complications managed collaboratively between allergy/immunology and rheumatology. See how to become a rheumatology NP.
- Dermatology NP – Atopic dermatitis (eczema) is treated by both specialties, and dupilumab prescribing occurs in both settings. Many patients with severe eczema see both a dermatology NP and an allergy NP. See how to become a dermatology NP.
For the full NP career pathway overview, see how to become a nurse practitioner.
Frequently asked questions
Is there a board certification specifically for allergy NPs? No. There is no ANCC or NPCB allergy/immunology NP certification exam. The ABAI certifies physicians only. ANCC offers no allergy or immunology credential at the RN level either. Most allergy/immunology NPs hold FNP-C, FNP-BC, or AGPCNP-BC as their primary certification.
Can NPs perform allergy skin testing independently? In most states, yes. Allergy skin testing (prick and intradermal) falls within the scope of practice for NPs in outpatient allergy settings. The practical requirement is clinical training – most new NPs to allergy receive supervised experience with a physician or experienced allergy APP before performing and interpreting skin tests independently.
Can NPs prescribe dupilumab and other allergy biologics? Yes. NPs with full practice authority can prescribe any FDA-approved biologic without physician co-signature. In collaborative agreement states, the collaborative agreement may specify prescribing scope. In practice, biologic prescribing is a routine part of allergy NP work in most settings.
Do I need a DNP to work in allergy/immunology? No. An MSN is sufficient for most allergy NP positions. Academic medical centers and some senior clinical leadership positions may prefer or require a DNP. The DNP does not change your state licensure scope in most states.
What is the job outlook for allergy/immunology NPs? Favorable. Allergist-immunologists are concentrated in metropolitan areas, and the growth of food allergy care and biologic therapy has created procedural roles (OIT programs, SCIT supervision, biologic administration) that NPs commonly fill. BLS projects nurse practitioner employment specifically to grow 41% from 2025 to 2035, from 336,300 jobs to 474,100 – the fastest growth rate of any detailed occupation in the projections. BLS does not project growth for individual NP specialties, so allergy/immunology-specific demand has to be judged from local job postings.
For salary data, geographic differentials, and compensation by setting, see the allergy immunology NP salary guide.
References
- U.S. Bureau of Labor Statistics, “Occupational Employment and Wage Statistics: Nurse Practitioners (SOC 29-1171),” May 2025 (released 15 May 2026).
- U.S. Bureau of Labor Statistics, “Occupational Outlook Handbook: Nurse Anesthetists, Nurse Midwives, and Nurse Practitioners,” Employment Projections 2025–2035 (released 27 August 2026, superseding the 2024–2034 round): 36% growth for the combined category, 399,000 jobs in 2025 rising to 543,000, approximately 32,200 openings per year, combined-category median $134,920 (May 2025). Nurse practitioners alone (SOC 29-1171) are projected to grow 41.0%, from 336,300 to 474,100.
- Food Allergy Research & Education (FARE), “Food Allergy Facts and Statistics for the U.S.,” April 2024 (33 million+; 1 in 13 children; 1 in 10 adults).
- U.S. Food and Drug Administration, “FDA Approves First Drug for Treatment of Peanut Allergy for Children (Palforzia),” January 31, 2020.
- U.S. Food and Drug Administration / Genentech, “Xolair (omalizumab) Approved to Reduce Allergic Reactions to Foods in Adults and Children,” February 16, 2024.
- Joint Task Force on Practice Parameters (AAAAI and ACAAI), “Practice Parameters and Guidelines,” current editions.
- American College of Allergy, Asthma and Immunology (ACAAI), “Allied Health Professional Membership and Continuing Education Resources,” 2025.
- American Nurses Credentialing Center (ANCC), “Family Nurse Practitioner (FNP-BC) and Adult-Gerontology Primary Care NP (AGPCNP-BC) Certification Requirements,” 2025.
- Nurse Practitioner Certification Board (NPCB, formerly AANPCB), “Family Nurse Practitioner (FNP-C) Certification Candidate Handbook,” 2026.
- Global Initiative for Asthma (GINA), “Global Strategy for Asthma Management and Prevention,” 2026 update (published 5 May 2026).
- American Nurses Credentialing Center (ANCC), “Certification Credentials Chart,” nursingworld.org (accessed September 2026).
- U.S. Food and Drug Administration, prescribing information for Dupixent (dupilumab), Nucala (mepolizumab), Fasenra (benralizumab), Tezspire (tezepelumab-ekko), and Palforzia (peanut allergen powder-dnfp), accessdata.fda.gov (current labels, 2024–2025 supplemental approvals).